Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 19- 52-wk high
- $126.40
- 52-wk low
- $23.30
- Prev close
- $116.10
- Mkt cap
- $7.28B
- Beta
- 2.16
- P/S
- 16.9x
Smart money
Earnings
Earnings came in 12.0% below what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $99.0M | $103.7M | $110.7M | $118.4M |
| Cost of what it sold | $48.2M | $49.7M | $53.6M | $55.9M |
| Gross profit | $50.8M | $54.0M | $57.1M | $62.5M |
| What it spent | ||||
| Research and development | $17.0M | $17.1M | $19.7M | $18.0M |
| Sales and admin | $56.8M | $69.9M | $76.1M | $80.7M |
| Other operating costs | $7.0M | — | — | — |
| Total operating expenses | $80.8M | $86.9M | $95.8M | $98.7M |
| What was left | ||||
| Operating profit | -$29.9M | -$32.9M | -$38.7M | -$36.3M |
| Profit before tax | -$26.9M | -$30.3M | -$44.0M | -$34.7M |
| Tax | $256.0K | $253.0K | $43.0K | -$311.0K |
| Net profit | -$27.1M | -$30.5M | -$44.0M | -$35.1M |
| EBITDA | -$20.9M | -$26.7M | -$32.2M | -$28.0M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Twist Bioscience (TWST) Is Down 5.1% After Upsized Equity Raise And Guidance Hike Has The Bull Case Changed?
NeutralAug 17Bank of America Corp DE Grows Stake in Twist Bioscience Corporation $TWST
NeutralAug 17T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position
NeutralAug 15